Literature DB >> 29181263

Cytogenetic study is not essential in patients with aplastic anemia.

Atreyee Dutta1, Rajib De2, Tuphan K Dolai2, Pradip K Mitra3, Ajanta Halder1.   

Abstract

Depending on contemporary treatment approach of aggressive immunosuppression, Aplastic Anemia (AA) is caused by immunological destruction of otherwise normal hematopoietic stem cells. The aim was to summarize the cytogenetic abnormalities in AA patients and the frequency of Fanconi Anemia (FA) in morphologically normal AA patients in eastern India. Ethical clearances were obtained from both institutions involved in this study. Out of 72800 patients attending the outpatient department, 520 pancytopenia patients were screened for AA after Bone marrow (BM) aspiration and biopsy. Samples were collected from 117 cases in 3 phases. 51 peripheral venous blood (PVB) samples in the first phase, 19 BM &amp; PVB paired samples in the second phase and 47 BM samples in third phase were collected followed by leukocyte and/or BM stem cell culture. Next GTG banding and karyotyping were performed. PVB was collected from 63 (< 50 years) AA patients and stress cytogenetics was done to diagnose FA. In the first phase of the study, out of 51 PVB samples, 1 (1.96%) showed a unique chromosomal abnormality, i.e. 45,XY,rob(14:21)(p10:q10)[20]. In the second phase of study, among 19 BM &amp; PVB paired samples, 1 (5.26%) showed abnormal karyotype i.e. 45,X,-Y[3]/46,XY[47]. In the third phase of the study, 47 BM samples showed normal karyotype. Only 6 (9.52%) cases were found positive for stress cytogenetics. A negligible percentage showing cytogenetic abnormality in such a considerable number of AA cases indicates that routine cytogenetic analysis of AA patient is not essential. A significant percentage was positive for stress cytogenetics; suggestive for FA, even the patients were morphologically normal.

Entities:  

Keywords:  Aplastic anemia; GTG banding; bone marrow failure; cytogenetic abnormalities; radial formation; stress cytogenetics

Year:  2017        PMID: 29181263      PMCID: PMC5698559     

Source DB:  PubMed          Journal:  Am J Blood Res        ISSN: 2160-1992


  44 in total

1.  A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents.

Authors:  M S Sasaki; A Tonomura
Journal:  Cancer Res       Date:  1973-08       Impact factor: 12.701

2.  Clonal cytogenetic abnormalities in patients with otherwise typical aplastic anemia.

Authors:  F R Appelbaum; J Barrall; R Storb; R Ramberg; K Doney; G E Sale; E D Thomas
Journal:  Exp Hematol       Date:  1987-12       Impact factor: 3.084

3.  Treatment of aplastic anemia in children with high dose methyl prednisolone.

Authors:  B R Agarwal; A Gulvady; K Bhalla; R Dalvi; Z E Currimbhoy
Journal:  Indian Pediatr       Date:  1995-10       Impact factor: 1.411

4.  Aplastic anemia or aplastic preleukemic syndrome?

Authors:  T Jameel; M Anwar; S I Abdi; M Saleem; P A Ahmad; M F Khattak
Journal:  Ann Hematol       Date:  1997 Nov-Dec       Impact factor: 3.673

5.  Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia.

Authors:  Jaroslaw P Maciejewski; Antonio Risitano; Elaine M Sloand; Olga Nunez; Neal S Young
Journal:  Blood       Date:  2002-05-01       Impact factor: 22.113

Review 6.  Treatment responses of childhood aplastic anaemia with chromosomal aberrations at diagnosis.

Authors:  Shouichi Ohga; Akira Ohara; Shigeyoshi Hibi; Seiji Kojima; Fumio Bessho; Shigeru Tsuchiya; Yukio Ohshima; Nobuyuki Yoshida; Yoshifumi Kashii; Shinichiro Nishimura; Kiyoshi Kawakami; Kenichi Nishikawa; Ichiro Tsukimoto
Journal:  Br J Haematol       Date:  2002-07       Impact factor: 6.998

7.  Evolution of acquired severe aplastic anaemia to myelodysplasia and subsequent leukaemia in adults.

Authors:  M M de Planque; H C Kluin-Nelemans; H J van Krieken; P M Kluin; A Brand; G C Beverstock; R Willemze; J J van Rood
Journal:  Br J Haematol       Date:  1988-09       Impact factor: 6.998

8.  Epidemiology, Clinico-Haematological Profile and Management of Aplastic Anaemia: AIIMS Experience.

Authors:  M Mahapatra; P K Singh; M Agarwal; M Prabhu; P Mishra; T Seth; S Tyagi; H P Patil; R Saxena
Journal:  J Assoc Physicians India       Date:  2015-03

9.  Cytogenetic profile of aplastic anaemia in Indian children.

Authors:  Vineeta Gupta; Akash Kumar; Isha Saini; Ajit Kumar Saxena
Journal:  Indian J Med Res       Date:  2013-03       Impact factor: 2.375

10.  Cytogenetics in paediatric aplastic anaemia: does it give an insight on the evolution of the disease?

Authors:  Kanjaksha Ghosh
Journal:  Indian J Med Res       Date:  2013-03       Impact factor: 2.375

View more
  1 in total

Review 1.  Acquired Aplastic Anemia as a Clonal Disorder of Hematopoietic Stem Cells.

Authors:  Katarzyna Brzeźniakiewicz-Janus; Joanna Rupa-Matysek; Lidia Gil
Journal:  Stem Cell Rev Rep       Date:  2020-06       Impact factor: 5.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.